RLAY - Relay Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RLAY is currently covered by 10 analysts with an average price target of $18.06. This is a potential upside of $13.4 (287.55%) from yesterday's end of day stock price of $4.66.

Relay Therapeutics 's activity chart (see below) currently has 72 price targets and 82 ratings on display. The stock rating distribution of RLAY is 94.74% BUY and 5.26% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10.11% with an average time for these price targets to be met of 27.91 days.

Highest price target for RLAY is $23, Lowest price target is $14, average price target is $18.33.

Most recent stock forecast was given by MICHAEL SCHMIDT from GUGGENHEIM on 04-Sep-2025. First documented stock forecast 10-Aug-2020.

Currently out of the existing stock ratings of RLAY, 36 are a BUY (94.74%), 2 are a HOLD (5.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$11.01 (275.94%)

$10

15 days ago
(04-Sep-2025)

1/5 (20%)

$11 (275.00%)

98

Buy

$14

$10.01 (250.88%)

$16

24 days ago
(26-Aug-2025)

2/23 (8.7%)

$10.46 (295.48%)

29

Buy

$23

$19.01 (476.44%)

$27

6 months 23 days ago
(27-Feb-2025)

0/8 (0%)

$19.25 (513.33%)

Buy

$18

$14.01 (351.13%)

$20

6 months 23 days ago
(27-Feb-2025)

0/3 (0%)

$14.25 (380.00%)

Buy

$21

$17.01 (426.32%)

$21

9 months 7 days ago
(12-Dec-2024)

0/11 (0%)

$16.22 (339.33%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RLAY (Relay Therapeutics ) average time for price targets to be met?

On average it took 27.91 days on average for the stock forecasts to be realized with a an average price target met ratio 10.11

Which analyst has the current highest performing score on RLAY (Relay Therapeutics ) with a proven track record?

ROBERT BURNS

Which analyst has the most public recommendations on RLAY (Relay Therapeutics )?

Robert Burns has 14 price targets and 9 ratings on RLAY

Which analyst is the currently most bullish on RLAY (Relay Therapeutics )?

Dane Leone with highest potential upside - $25.01

Which analyst is the currently most reserved on RLAY (Relay Therapeutics )?

Matthew Biegler with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?